TEVA Jan 2026 4.000 put
| Previous close | 0.0100 |
| Open | 1.0000 |
| Bid | 0.0000 |
| Ask | 1.0000 |
| Strike | 4.00 |
| Expiry date | 2026-01-16 |
| Day's range | 0.0100 - 1.0000 |
| Contract range | N/A |
| Volume | |
| Open interest | 64 |
- Yahoo Finance Video
Affirm stock sinking, Good Buy or Goodbye: Market Domination
Stocks (^DJI, ^IXIC, ^GSPC) search for direction ahead of Wednesday's market close with the Dow Jones Industrial Average holding in the green. After topping fiscal third-quarter revenue estimates and narrowing expected losses per share, Affirm shares (AFRM) are now sinking in the afternoon and analysts have an idea of what the cause is. Tripadvisor (TRIP), Teva Pharmaceutical Industries (TEVA), and Dutch Bros (BROS) are also reporting earnings. Defiance ETFs CEO and CIO Sylvia Jablonski joins Market Domination for the latest installment of Yahoo Finance's Good Buy or Goodbye to talk about the latest trend in clean energy investing: Uranium. Dine Brands (DIN) CEO John Peyton — whose company owns IHOP and Applebee's — discusses consumer spending patterns at his restaurants. This post was written by Luke Carberry Mogan.
Insider MonkeyTeva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript May 8, 2024 Teva Pharmaceutical Industries Limited misses on earnings expectations. Reported EPS is $-0.12161 EPS, expectations were $0.51. Teva Pharmaceutical Industries Limited isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […]
Simply Wall St.Teva Pharmaceutical Industries First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Teva Pharmaceutical Industries ( NYSE:TEVA ) First Quarter 2024 Results Key Financial Results Revenue: US$3.82b (up...
